Brief: Cyclacel Pharmaceuticals Reports First Quarter 2022 Results
May 11 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O :
* CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* CYCLACEL PHARMACEUTICALS INC - CASH RUNWAY THROUGH
MID-2023
* CYCLACEL PHARMACEUTICALS INC QTRLY NET LOSS PER SHARE -
BASIC
AND DILUTED $0.42
Source text for Eikon: ID:nGNX5CSK04
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Green Med Solution
See all newsBrief: Bio Green Med Solution Announces Business Combination Agreement To Acquire Future NRG
Bio Green Med Solution Q1 product revenue hits $0.8 mln, net loss narrows
Brief: Bio Green Med Solution Inc Q1 Net Income USD -197 Thousand
Malaysia's Bio Green Med Solution Q4 net loss narrows
Brief: Bio Green Med Solution Inc Q4 Net Income USD -611 Thousand